Global University Venturing

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Subsidiaries of Astellas and Novartis co-led a series B round that took Harvard's cancer treatment developer's overall funding to $60m.

Pavilion Capital and Hansjörg Wyss featured in a series B round for Harvard-founded ReadCoor, whose existing shareholders also include Lilly Asia Ventures.

Fusion Pharmaceuticals has now raised $171m altogether to deliver cancer radiopharmaceuticals based on McMaster University research.

Annual data review: 2019

Sector analysis: Transport

In our annual survey of corporate venturing industry leaders, we asked what the most important trends were in 2019 and sought their insights into the big opportunities of 2020.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Jasper Therapeutics, based in part on Stanford research, has raised a $15m series A extension on the back of early clinical results from its blood transplant conditioning program.

Stanford-StartX Fund-backed Inflammatix received series C funding led by Grey Sky ahead of the European release of its acute infection diagnostics platform.

Insight Partners agreed to acquire IoT security software provider Armis in a rollover transaction that featured a $100m commitment from Alphabet. The deal forms part of the IoT space to which corporates have not been indifferent over the past decade.